Members of the Drosophila behavior/human splicing protein family, including splicing factor proline/glutamine rich (SFPQ), non-POU domain-containing octamer-binding protein (NONO), and paraspeckle protein component 1 (PSPC1), are abundantly expressed in testicular Sertoli cells (SCs), but their roles remain obscure. Here, we show that treatment with mono-(2-ethylhexyl) phthalate (MEHP), a well-known SC toxicant, selectively stimulates the expression levels of NONO and PSPC1. Simultaneous inhibition of NONO and PSPC1 expression in SCs enhances MEHP-induced oxidative stress and potentiates SC death. Mechanistically, NONO and PSPC1 transcriptionally activate aldehyde dehydrogenase 1 (Aldh1a1), by synergistically binding to the distinct CCGGAGTC sequence in the Aldh1a1 promoter. Together, the NONO/PSPC1-ALDH1A1 cascade may serve as an indispensable defense mechanism against MEHP insult in SCs.
thereby compromises testicular steroidogenesis [3] . Although the physiopathological responses to MEHP treatment of the testes have been well documented, the molecular mechanisms through which these responses are directed remain largely unknown.
The Drosophila behavior/human splicing (DBHS) protein family, consisting of splicing factor proline/glutamine rich (SFPQ), non-POU domain-containing octamer-binding protein (NONO), and paraspeckle protein component 1 (PSPC1), is frequently identified engaging in multiple crucial cellular processes including transcriptional regulation, RNA metabolism, DNA repair, post-transcriptional processing and export, and regulation of cell cycle. Therefore, DBHS proteins are regarded as multifunctional molecules involved in various aspects of cell biology [4] . However, these proteins rarely function alone. In many cases, NONO and SFPQ are coexisted [5] , suggesting that the complicated and delicate interaction between DBHS proteins is indispensible for their normal function. DBHS proteins are ubiquitously expressed. Of particular interest, all three DBHS proteins have been shown to be dominantly expressed in SCs. Interestingly, structural and biological data show that NONO is one of the coregulators of androgen receptor (AR), which plays a key role in SCs biology and spermatogenesis [6] . Nevertheless, the functional details and the corresponding underlying mechanisms of DBHS proteins in SCs remain largely unknown.
Aldehyde dehydrogenases (ALDHs) generated during metabolism of endobiotic and xenobiotic compounds and acting as the major aldehyde scavengers, play key roles in abrogating oxidative stress during lipid peroxidation [7] . Many ALDHs are also important in the regulation of homeostatic pathways such as synthesis of vitamins and metabolism of lipid. Expression of ALDHs is usually upregulated in the presence of abiotic and biotic stress. Such stressresponsive expression of ALDHs is believed to serve as a fundamental protective mechanism against a variety of environmental stressors [8] . Recent advance in this field have shown that treatment with MEHP in the immortalized TM4 SCs line results in a significant increase in the expression level of aldehyde dehydrogenase 1 (ALDH1A1) [9] , but the functional meaning of this upregulation remains to be further delineated.
In the present communication, we analyzed the expression patterns of the three DBHS proteins in MEHP-exposed testis and SCs. Moreover, we provide the in vitro evidence that the NONO/PSPC1 complex regulates SCs response to MEHP treatment through direct modulation of ALDH1A1 signaling. Overall, our results underscore the fundamental importance of distinct DBHS members in SCs injury.
Materials and methods

Animal model
Ten-week-old male C57BL/6 mice were obtained from the Animal Research Center of our university. Mice received a single dose of MEHP (1 gÁkg À1 ; Sigma, Shanghai, China)
by oral gavage. Control animals received a similar volume of vehicle (corn oil). About 12 h later, mice were sacrificed by CO 2 inhalation (n = 7 for each group). All experimental procedures were approved by the local ethical committee. , ThermoFisher Scientific Inc., Shanghai, China) for 2 days before being subjected to MEHP exposure.
Cell treatment
Immunohistochemistry
A Vectastain Elite ABC kit (Vector Laboratories, Inc., Burlingame, CA, USA) was used to carry out the immunohistochemiscal staining, as described previously [10] . Briefly, for antigen retrieval, slides were incubated with citrate buffer (pH 6.0, 10 mM) in a pressure cooker at 95°C for 30 min. Sections were then treated with 3% H 2 O 2 in methanol for 10 min to destroy the endogenous peroxidase activity. Subsequently, sections were incubated with the primary antibodies diluted in phosphate-buffered saline at 4°C overnight in a moist box, followed by incubation with biotinylated goat anti-rabbit IgG and VECTASTAINÒ ABC Reagent consecutively for 1 h, respectively. Peroxidases were detected with diaminobenzidine as a chromogen (Sigma). The primary antibodies used were rabbit-anti NONO (1 : 100; Proteintech, Wuhan, China), rabbit-anti PSPC1 (1 : 50; Abcam, Shanghai, China), rabbit-anti SFPQ (1 : 50; Proteintech), and rabbit-anti ALDH1A1 (1 : 100; ThermoFisher Scientific). Slides incubated with a preabsorbed antibody instead of primary antibody served as negative control.
Immunoblotting
Immunoblotting was performed as described elsewhere [11] . Membranes were then incubated with various primary antibodies as indicated above in blocking solution overnight at 4°C. Final signals were detected by using an enhance chemiluminescence kit (Amersham Biosciences, Shanghai, China). Densitometric analysis was performed by using IM-AGE J software (http://rsbweb.nih.gov/ij/) and normalized for b-ACTIN staining.
Quantitative RT-PCR
Quantitative RT-PCR (RT-qPCR) was carried out according to previous report [12] . RNA was purified with an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Eluted RNA was reverse-transcribed using SuperScriptÒ III kit (ThermoFisher Scientific) and PCR was set up according to ThermoFisher's RT system protocol. The primers used in this study were described elsewhere [5] . Amplification of Gapdh was served as the internal control. PCR products were then quantified by SYBR green intercalation using the MiniOpticon system (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Measurement of apoptosis
Evaluation of cellular apoptosis after MEHP exposure was achieved by staining cells with Annexin-V fluorescein isothiocyanate/propidium iodide (PI) followed by flow cytometry analysis [13] . A dot plot was set up with the yaxis as FL-2 for PI staining and the x-axis as FL-1 for Annexin-V.
Evaluation of oxidant and antioxidant status
The oxidant and antioxidant statuses were determined in the cellular extracts as described previously [14] . Briefly, cells in ice-cold PBS solution were disrupted by an ultrasonic processor (Misonix, Farmingdale, NY, USA) and centrifuged at 1000 g for 15 min at 4°C. Subsequently, the malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and phospholipid hydroperoxide glutathione peroxidase (GSH-Px) levels in the supernatant were assayed spectrophotometrically using commercial kits (Jiancheng Bioengineering, Nanjing, China), by measuring absorbance at 532-, 405-, 405-, and 412-nm wavelengths, respectively.
Luciferase reporter assay
TM4 cells were transfected with pSCT-GAL93-NONO, pSCT-GAL93-PSPC1, or their corresponding vectors (Addgene, Cambridge, MA, USA) by using Lipofectamine 2000 (Invitrogen). About 48 h later, cells were transfected using DharmaFECT DUO (Dharmacon, Shanghai, China) with a human ALDH1A1 promoter reporter construct system (SwitchGear Genomics, Menlo Park, CA, USA), followed by MEHP exposure as described above. Luciferase activity measurements were performed in LightSwitch assay reagents as instructed in the manufacturer's protocol.
Chromatin immunoprecipitations
TM4 cells, TM4 cells transfected with shLenti-Pspc1, or TM4 cells transfected with shLenti-Nono were treated with MEHP for 12 h. Subsequent chromatin immunoprecipitations (ChIP) assay was performed as described elsewhere [15, 16] . Recovery and preparation of DNA was followed by PCR using primers flanking the two regions of 
Data presentation and statistical analysis
Experiments were repeated at least three times, and one representative result from at least three similar results is presented. Quantitative data, presented as mean AE SEM, were analyzed for statistically significant differences using analysis of variance, followed by Tukey's test. A value of P < 0.05 was considered significant.
Results
Induction of distinct DBHS proteins in SCs by MEHP
Preliminary histochemical analysis of protein expression profile of MEHP-treated testis showed a notable increase in the expression levels of NONO and PSPC1 in SCs, whereas SFPQ expression was unaffected (arrows in Fig. 1A ). To validate this, we treated TM4 cells with 200 lM MEHP for 6 or 12 h and then subjected these cells to immunoblotting analysis. In line with the in vivo results, NONO expression level was significantly evoked at both time-points, while MEHP could only stimulate PSPC1 expression in the presence of longer MEHP exposure. In contrast, SFPQ expression remained relatively constant, regardless of the duration of MEHP treatment (Fig. 1B) . SFPQ acts as an essential coactivator for the transcription of adenosine deaminase B2 (ADARB2), so the latter has now being used to as a reporter for functional transcriptional activity of SFPQ [4] . As shown in Fig. 1C , no difference in the mRNA expression of ADARB2 was observed in MEHP-treated cells, further confirming our observation.
Simultaneous inhibition of NONO and PSPC1 aggravates MEHP damage DBHS proteins usually act reciprocally. So, NONO and PSPC1 may cooperatively regulate SCs response against MEHP insult. To study this, we established TM4 cells stably cotransfected with pGFP-C-shLentiNono/Pspc1. The inhibition of two targets was validated using RT-qPCR ( Fig. 2A ) and immunoblotting analyses (Fig. 2B) . By using western blot, a strong reduction was detected for both proteins in three passages and six passages of SCs (Fig. S1 ), suggesting that NONO/PSPC1 knockdown in our study was relatively stable over time. Interestingly, simultaneous inhibition of NONO and PSPC1 significantly promoted MEHPinduced cell apoptosis (Fig. 2C,D) . Additionally, the spectrophotometrical analysis revealed a significant increase in the MEHP-elicited MDA content of TM4 cells stably cotransfected with pGFP-C-shLenti-Nono/ Pspc1 (Fig. 2E) . Consistently, the activities of SOD, CAT, and GSH-Px were all notably reduced in the NONO/PSPC1-inhibited TM4 cells compared with those in the TM4 cells transfected with empty vector (Fig. 2F-H) , indicating that the NONO/PSPC1 deficiency-induced deleterious effects upon MEHP treatment may involve altered oxidative stress status. In the meantime, we have carried out the single knockdown experiments serving as parallel controls. As shown in Fig. S2 , attenuation of NONO or PSPC1 expression level appeared to have no significant deleterious effects on MEHP-treated SCs, as compared to the double knockdown results, suggesting that in SCs, NONO and PSPC1 may integrate into a functional complex by interacting with each other, and they are required together for the modulation of SCs response against MEHP insult. As shRNA depletion studies may suffer from off-target effects, we subsequently investigated the effect of NONO/PSPC1 overexpression. Toward this, pLenti-GIII-CMV-NONO and pLenti-GIII-CMV-PSPC1 were transiently expressed together in TM4 cells. As expectedly, overexpression of NONO and PSPC1 significantly improve the SCs responses (reduction in apoptosis, decrease in the MDA content, and promotion of SOD activity) in the presence of MEHP exposure (Fig. S3 ). These data collectively confirm the protective effects of NONO and PSPC1 against MEHP-induced SCs injury.
NONO/PSPC1 deficiency causes ALDH1A1 downregulation
Our parallel microarray results showed MEHP treatment induced a dramatic reduction in the Aldh1a1 expression level in Nono/Pspc1-deficient TM4 cells. This observation has been further validated, in the current study, by RT-qPCR (Fig. 3A) and immunoblotting analyses (Fig. 3B) . Moreover, consistent with our in vitro data, histochemical analysis revealed a significant induction of ALDH1A1 expression in MEHPexposed testis (Fig. 3C) , indicative of an association between ALDH1A1 and NONO/PSPC1 expression upon MEHP insult. To ask whether NONO and PSPC1 act synergically in the modulation of ALDH1A1 expression, we transfected TM4 cells with pGFP-C-shLenti-Nono or pGFP-C-shLenti-Pspc1, or cotransfected with two particles and then subjected these cells to RT-qPCR analysis. Suppression of NONO or PSPC1 alone could cause Aldh1a1 downregulation in the presence of MEHP, but cosuppression exerted the most significant inhibitory effects on Aldh1a1 level (Fig. 3D) . To further investigate whether ALDH1A1 functions directly or indirectly in the downstream of NONO/PSPC1 pathway, we incubated cells with recombinant ALDH1A1 protein (R-ALDH1A1) in the presence of MEHP exposure. Supplement with R-ALDH1A1 efficiently reduced the MEHP-elicited apoptosis (Fig. 3E ) and oxidative stress (Fig. 3F ) in NONO/PSPC1-deficient TM4 cells. Thus, ALDH1A1 may function directly in SCs upon MEHP challenge. Lastly, we studied whether NONO/PSPC1 could directly regulate Aldh1a1 expression at the transcriptional level. Transfection with pSCT-GAL93-NONO, pSCT-GAL93-PSPC1, or with pSCT-GAL93-NONO/ PSPC1 could all significantly upregulate MEHPinduced Aldh1a1 promoter activity, with the highest value being detected in TM4 cells transfected with pSCT-GAL93-NONO/PSPC1 (Fig. 4A) . Sequence analysis of the Aldh1a1 major promoter revealed two potential binding sites with more than 70% homology to the NONO consensus binding site (Fig. 4B) . We then performed ChIP assays by using primers encompassing different fragments of the Aldh1a1 promoter region (P1 and P2). In the presence of MEHP, NONO and PSPC1 were both recruited to the À405 to À398 bp region of the Aldh1a1 promoter (Fig. 4C) . Interestingly, stable knockdown of NONO expression abolished the PSPC1 recruitment onto P2 region, whereas stable knockdown of PSPC1 expression had no effect on the NONO recruitment onto P2 region (Fig. 4D) . Thus, in MEHP-treated SCs, NONO may serve as a key component in the synergetic upregulation of Aldh1a1 transcription by the NONO/PSPC1 complex.
Discussion
Phthalates are believed to exert their reprotoxic effects by directly interacting with different members of the nuclear proteins, or indirectly by modulating the expression of nuclear proteins' targets [4] . In favor of this conjecture, it has been shown that MEHP could upregulate the expression of LXRa, SREBP members, and their corresponding downstream genes involved in the lipid and cholesterol synthesis in testis [17] . Similarly, MEHP stimulates PPARc at the transcriptional level and results in reproductive organ toxicities in rodents [18] . Taken together, multiple levels of transcriptional regulation are expected in MEHP-exposed testis. In the current study, we found MEHP treatment leads to a notable increase in the expression levels of NONO and PSPC1 in SCs (Fig. 1A,B) , also indicating that these two DBHS proteins may play unique roles in SCs response. Our data thus discover additional transcriptional control components and would help to establish gene regulatory network underlying the reprotoxic effects of MEHP. PSPC1, NONO, and SFPQ are all dominantly expressed in SCs and interact reciprocally, as revealed by coimmunoprecipitation analysis [6] . However, in our study, only NONO and PSPC1 were observed to be upregulated in MEHP-treated SCs (Fig. 1B,C) , suggestive of intrinsic functional differences among these DBHS proteins. Selective activation of certain transcriptional coregulators occurs very often in MEHPexposed SCs. For example, metastasis-associated protein 1 (MTA1) and MTA2, two essential components of the Mi-2/nucleosome remodeling and deacetylase complex that regulates crucial cellular pathways by modifying the acetylation status of the target gene chromatin, are both abundantly expressed in SCs. But so far, only MTA1 is found to be induced by MEHP treatment in SCs, where this chromatin modifier acts as an indispensible modulator of the NF-jB-regulated FasL expression [2] , and of the transcriptional expression of TIMP2 signaling [11] . Therefore, selective induction of the expression of NONO and PSPC1, but not of SFPQ, may reflect an intrinsic character in MEHP-treated SCs. Alternatively, from a functional standpoint, DBHS proteins act bifunctionally as positive and negative transcriptional regulators: Transcriptional repression by DBHS proteins is largely dependent on SFPQ. The latter directly binds to target gene promoters and then usually recruits epigenetic silencers such as Sin3A and HDACs. In contrast, NONO usually serves as a transcriptional activator and in many cases involves binding and interacting with other DBHS members [4] . High-throughput analyses have been used to link gene expression profile to mechanisms of MEHP toxicity in SCs. The overall pattern of gene expression was one of cellular switchon [9] . In this context, upregulation of NONO/PSPC1 may serve as a certain protective mechanism that is thereby guaranteed to initiate a defensive or reparative response against MEHP insult. Of note, NONO does not always interact with PSPC1 in transcriptionally active contexts. For example, it has been previously shown that a complex of SFPQ/NONO can regulate basal and cAMP-dependent transcription of Cyp17 and Rbp4 [4] . So, the complicated association and delicate balance between NONO and other DBHS proteins in the presence of an acute environmental insult merits further investigation. Despite the initial identification of DBHS proteins as the transcriptional coregulators of AR-mediated transactivation, we failed to detect any alteration in the expression and activity of AR in MEHP-exposed SCs (our unpublished data). Indeed, it has been shown that the deleterious effects of MEHP remain unchanged in testes from AR-knockout mouse [19] . Therefore, the harmful effects of phthalates do not involve, directly or indirectly, the AR signaling, and NONO and PSPC1 may target other pathways in response to MEHP challenge. ALDHs metabolize aldehydes that are generated during the oxidative degradation of lipid membranes and are usually highly reactive and toxic, and thereby mitigate oxidative stress in eukaryotic organisms [7] . Recent study using gene expression microarray has identified upregulation of ALDH1A1 expression and activity as an essential stress response in MEHP-treated TM4 cells [9] . However, the transcriptional or posttranscriptional mechanisms controlling ALDH1A1 expression in response to MEHP insult remain unexplored. To this end, we have shown that NONO/PSPC1 complex directly regulates Aldh1a1 transcription, and upon MEHP stimulation, NONO and PSPC1 were recruited onto the distinct region of Aldh1a1 promoter and is required for its transactivation (Fig. 4) . Of note, we reason that PSPC1 may indirectly bind to the Aldh1a1 promoter region via binding to NONO firstly, because stable knockdown of NONO expression could substantially abolish the PSPC1 recruitment onto Aldh1a1 promoter, but not vice versa (Fig. 4D) . Thus, PSPC1 may positively regulate Aldh1a1 transactivation via interaction with NONO in a piggy-back manner (Fig. 4E) . Previously, Park et al. [20] have demonstrated that NONO exerts its important transcription activator effect on OCT4 expression via specifically binding to the conserved CCGGTGAC sequence in the promoter. Consistently, in the current study, MEHP-elicited NONO/PSPC1 was also recruited to the distinct region of Aldh1a1 promoter (CCGGAGTC), which exhibits 80% homology to the NONO consensus binding site. Thus, the binding sites of NONO/PSPC1 onto promoter in different genes appear relatively conserved. Our results also provide a molecular mechanistic explanation for the transactivation of Aldh1a1 expression by MEHP treatment.
In conclusion, our comprehensive findings provide novel clues for the possible involvement of NONO/ PSPC1-ALDH1A1 in the modulation of SCs response to MEHP challenge. Specifically, MEHP-elicited NONO and PSPC1 are reciprocally recruited to the conserved binding site of Aldh1a1 promoter and stimulate the transactivation of Aldh1a1 gene. Disruption of this synergetic function of NONO/PSPC1 should result in the impairment of ALDH1A1 expression and activity, lead to deregulated oxidative stress, and thus cause SCs apoptosis and corresponding damage in germ cell development (Fig. 4E) . Overall, NONO/PSPC1-ALDH1A1 cascade may serve as an indispensable defense response mechanism against MEHP insult in SCs.
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